Company Analysis

Palisade Bio, Inc. (PALI)

Nasdaq: PALI · Biological Products, (No Diagnostic Substances) · Carlsbad, CA · filing with the SEC since 2006
Grade4.8
◀ Past 1.4● Present 4.4▶ Future 7.3
5 est.

Who runs Palisade Bio, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Finley John David
CEO CFO. First filing Apr 2021, latest Oct 7, 2026, 13 filings in all.
Officers reporting now
3
of 8 people with a filing in the last fifteen months
Directors reporting now
5
26 people on the record since 2007
Officerssales are open-market, Oct 21, 2025 to Oct 21, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Capers Julien E.See RemarksOct 2026Oct 21, 2026none
Finley John DavidCEO CFOApr 2021Oct 7, 20262 · $300,000
Jones Mitchell LawrenceSee RemarksSep 2023Oct 7, 20262 · $100,000
Directorssales are open-market, Oct 21, 2025 to Oct 21, 2026
NameRoleFirst filingLatest filingSales, 12 months
Williams Donald AllendirectorApr 2021Oct 5, 2026none
Baltera Robert Jr.directorJun 2026Jul 10, 2026none
Chuang EmildirectorJul 2025Jun 12, 2026none
Wei BinxiandirectorJul 2019Jun 12, 2026none
Zwick Jordan MichaeldirectorJun 2026Jun 12, 2026none
Earlier names on the record19, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton PALI · research, not advice